Crossmark

Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study

Crossref DOI link: https://doi.org/10.1186/s13613-022-01004-w

Published Print: 2022

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fisher, Richard

Moore, Gary W.

Mitchell, Michael J.

Dai, Letian

Crichton, Siobhan

Lumlertgul, Nuttha

Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02486614 at ClinicalTrials.gov

Documents that mention this clinical trial

Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
https://doi.org/10.1186/s13613-022-01004-w
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-022-01004-w

Content Type: article

Copyright: Copyright © 2022 The Author(s) 2022. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below